WASHINGTON, July 18, 2019 /PRNewswire/ -- Howard University has elevated Andrea D. Jackson, DDS, as dean of the College of Dentistry where she had been serving as interim dean since July 2018.

ATLANTA, July 18, 2019 /PRNewswire/ -- DLH Holdings Corp. (NASDAQ: DLHC) ("DLH" or the "Company"), a leading healthcare and human services provider to the federal government, today announced that it will release its third quarter financial results for the period ended June 30, 2019 on August 5, 2019 after the market close. DLH

PARAMUS, N.J., July 18, 2019 /PRNewswire/ -- Nuvolo, the world's fastest growing Workplace Management Company, built on ServiceNow, today announced that it has raised $12MM in Series B capital led by Kaiser Permanente Ventures with follow-on investments from GE Ventures, NEA and ServiceNow Ventures.  "Nuvolo is committed to growing its leadership position in

CRANFORD, N.J., July 18, 2019 /PRNewswire/ -- Atlantis Healthcare US (AHUS) announced three new hires that represent a strategic shift in the company's business model, expanding account management and adding creative and digital services including user experience design. The new framework allows the AH team to apply their core expertise in health psychology against a muc

TARRYTOWN, N.Y., July 18, 2019 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced the winners of the seventh annual Regeneron Prize for Creative Innovation. The country's leading research universities were asked to nominate top candidates for the Regeneron Prize in the 'graduate student' and 'postdoctoral fellow' categories. In to

GERMANTOWN, Md., July 18, 2019 /PRNewswire/ -- Neuralstem, Inc. (Nasdaq: CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell and small molecule technologies, announced that Mary Ann Gray, Ph.D. has been appointed to the Company's Board of Directors."We are please

HOUSTON, July 18, 2019 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today announced additional positive interim safety and efficacy data from its ongoing open label, single arm Phase 1/2 study of Annamycin in

OAK BROOK, Ill., July 18, 2019 /PRNewswire/ -- The end of the academic year signals report card time for millions of households across America. Likewise, parents recently assigned grades to the status of their kids' oral health as a part of the Children's Oral Health Survey. Few parents (21%) nationwide would give their kids an excellent bill of oral health.V

JERSEY CITY, N.J., July 18, 2019 /PRNewswire/ -- Legal-Bay LLC, The Pre Settlement Funding Company, announced today that they are preparing for an influx of hernia mesh lawsuits in the coming months.